However, studies focusing on CDH1-unaltered ILC are scarce, and several aspects regarding its clinicopathological (age, site, menopausal status, T factor, N factor, and tumor grade) and molecular characteristics (tumor mutational burden and co-mutated genes) remain unknown. The gene discussed is CDH1; the disease is neoplasm.